Insider Transaction Report for Mark William Lowdell

Mark William Lowdell, Chief Scientific Officer of Inmune Bio, Inc., exercised 7,211 stock options on July 2, 2026. These options were part of the April 2024 offerings and were amended on December 22, 2025. The exercise price was $1.40 per share, and the transaction involved 7,211 shares of Common Stock. This action was taken as part of an agreement with the issuer to extend the maturity date of the remaining warrants from June 30, 2026, to December 31, 2027. Following this transaction, Lowdell directly owns 1,518,017 shares of Common Stock and holds 7,212 warrants. The warrant exercise price was $0.125 per share.